Mersana Therapeutics, Inc.·4

Jan 19, 6:03 PM ET

MISRA TUSHAR 4

4 · Mersana Therapeutics, Inc. · Filed Jan 19, 2022

Insider Transaction Report

Form 4
Period: 2022-01-14
MISRA TUSHAR
Chief Manufacturing Officer
Transactions
  • Award

    Restricted Stock Units

    2022-01-14+5,8335,833 total
    Common Stock (5,833 underlying)
  • Award

    Stock Option (right to buy)

    2022-01-14+26,25026,250 total
    Exercise: $6.28Exp: 2032-01-13Common Stock (26,250 underlying)
Footnotes (3)
  • [F1]The option vests in equal quarterly installments over the first four years after the vesting commencement date, January 14, 2022.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F3]The restricted stock units vest in equal annual installments over the first four years after the vesting commencement date, January 14, 2022.

Documents

1 file
  • 4
    tm223926-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT